Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2013 2
2014 1
2016 1
2018 3
2019 12
2020 15
2021 21
2022 8
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Mutational Signatures in Salivary Gland Carcinomas.
Chrysovergis A, Papanikolaou V, Spyropoulou D, Roukas D, Asimakopoulos AD, Papanastasiou G, Mastronikoli S, Falidas E, Papouliakos S, Tsiambas E, Pantos P, Ragos V, Peschos D, Mastronikolis N, Kyrodimos E. Chrysovergis A, et al. Among authors: kyrodimos e. Cancer Diagn Progn. 2023 Jul 3;3(4):411-415. doi: 10.21873/cdp.10233. eCollection 2023 Jul-Aug. Cancer Diagn Progn. 2023. PMID: 37405215 Free PMC article. Review.
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma.
Papanikolaou V, Kyrodimos E, Mastronikolis N, Asimakopoulos AD, Papanastasiou G, Tsiambas E, Spyropoulou D, Katsinis S, Manoli A, Papouliakos S, Pantos P, Ragos V, Peschos D, Chrysovergis A. Papanikolaou V, et al. Among authors: kyrodimos e. Cancer Diagn Progn. 2023 Mar 3;3(2):151-156. doi: 10.21873/cdp.10194. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875315 Free PMC article. Review.
Machine learning approaches to predict drug efficacy and toxicity in oncology.
Badwan BA, Liaropoulos G, Kyrodimos E, Skaltsas D, Tsirigos A, Gorgoulis VG. Badwan BA, et al. Among authors: kyrodimos e. Cell Rep Methods. 2023 Feb 21;3(2):100413. doi: 10.1016/j.crmeth.2023.100413. eCollection 2023 Feb 27. Cell Rep Methods. 2023. PMID: 36936080 Free PMC article. Review.
Micro-RNAs signatures in papillary thyroid carcinoma.
Mastronikolis N, Tsiambas E, Roukas D, Fotiades P, Chrysovergis A, Papanikolaou V, Kyrodimos E, Mastronikoli S, Niotis A, Ragos V. Mastronikolis N, et al. Among authors: kyrodimos e. J BUON. 2020 Sep-Oct;25(5):2144-2146. J BUON. 2020. PMID: 33277828 Free article. Review.
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.
Moutafi M, Koliou GA, Papaxoinis G, Economopoulou P, Kotsantis I, Gkotzamanidou M, Anastasiou M, Pectasides D, Kyrodimos E, Delides A, Giotakis E, Papadimitriou NG, Panayiotides IG, Perisanidis C, Fernandez AI, Xirou V, Poulios C, Gagari E, Yaghoobi V, Gavrielatou N, Shafi S, Aung TN, Kougioumtzopoulou A, Kouloulias V, Palialexis K, Gkolfinopoulos S, Strati A, Lianidou E, Fountzilas G, Rimm DL, Foukas PG, Psyrri A. Moutafi M, et al. Among authors: kyrodimos e. Cancer Res Commun. 2023 Aug 10;3(8):1514-1523. doi: 10.1158/2767-9764.CRC-23-0051. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37575280 Free PMC article. Clinical Trial.
78 results